AbVitro

Juno Buyout Puts Single-Cell Sequencing In Spotlight
Investors.com
Sat, 01/16/16 - 11:26 am
Juno Therapeutics
M&A
Celgene
AbVitro
single-cell sequencing
Juno Acquires Harvard Spinout, AbVitro, For $125M To Discover More Cancer Immunotherapies
Forbes
Mon, 01/11/16 - 11:55 am
Juno Therapeutics
AbVitro
M&A
immunotherapy